MAY 01, 2018 05:00 PM PDT

The Microfluidic Device: Future Replacement for Bone Marrow Biopsy in Multiple Myeloma

Collaborators from multiple research institutions shared their findings on a new diagnostic device in the journal Integrative Biology in late April 2018; the group developed and tested a less invasive diagnostic and monitoring tool for Multiple Myeloma (MM).  This disease occurs in the bone marrow and currently requires a bone marrow biopsy for diagnosis and subsequent follow ups to monitor disease.  Bone Marrow biopsies are incredibly painful and, while incredibly rich in diagnostic value, they are terrible for patients to endure.  This research promises a new option where a plastic chip-based technology is used with whole blood to detect MM cells or circulating plasma cells (CPCs). 

The chip is termed a microfluidic device with monoclonal anti-CD138 antibodies.  The researchers tested the chip with whole blood drawn from patients with a known immuno-phenotype (CD38/CD56/CD45 panel positive) for Monoclonal Gammopathy of Unknown Significance (MGUS), Smoldering MM (SMM), and symptomatic MM.  Researchers found that 78% of patients with MGUS were correctly identified and 100% of all MM/SMM patients were identified.  Their positive and negative controls were also noted to be accurately identified.  Not only was presence of CPCs detected accurately, the sensitivity to CPC levels were detected.  There was a noted higher level of CPCs in circulation detected in patients with symptomatic MM as compared to the other disease states evaluated.  The microfluidic device captures the CPCs and they can be washed off the device and utilized in advanced molecular and cytogenetic techniques for further genetic profiling.  Currently, bone marrow biopsy samples are utilized, as well as whole blood, for this testing in patients.

The researchers also pointed out the value of this device in its cost to the healthcare system.  Prior chip iterations have had significant cost, rendering this method of analysis as too much of a financial burden to healthcare and patients to be implemented broadly.  The particular chip they have reported designed is made of plastic and can be injection molded quickly and inexpensively.  This increases its chances of making further on the market and being utilized broadly. 

Proponents of this technology share that the bone marrow biopsy will no longer be needed but it is still a gold standard for diagnosis and provides a glimpse at the health of an individual’s bone marrow and immune system.  There may definitely be a future for this technology for MM, and other cancers, especially as it relates to sparing a patient the agony of a biopsy; however, other information is gleaned from that biopsy than just the presence of plasma cell expansion. 

Sources: Integrative Biology, University of Kansas News,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 06, 2018
Cell & Molecular Biology
JUN 06, 2018
New Role for Protein Complex Provides Insight Into Cancer Development
Researchers found that RSC plays an important role in chromosome distribution....
JUL 17, 2018
Cancer
JUL 17, 2018
Immunotherapy Diversification: From CAR-T cells to CAR-NK cells
New advances have made it possible for immunotherapy researchers to use natural killer cells, which are our body's normal defense for cancerous cells, to target tumors....
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
SEP 11, 2018
Cannabis Sciences
SEP 11, 2018
New Evidence Shows Marijuana Smoke is Not the Same as Cigarette Smoke, at Least, in Terms of Lung Disease.
A recent report published in the journal Breathe by scientists in the UK suggests that chronic marijuana smoking may not cause the same deleterious effects...
OCT 02, 2018
Health & Medicine
OCT 02, 2018
Many Patients Are Unaware of Increased Cancer Risk
Just as recently as a few decades ago, many common health screenings were not readily available. Mammography, for breast cancer detection, wasn't ...
OCT 03, 2018
Cell & Molecular Biology
OCT 03, 2018
Single Cell Modified in CAR T Therapy Causes Deadly Relapse
One cell meant a very different outcome for a patient that was the recipient of a cutting-edge cancer therapy....
Loading Comments...